Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair
María Ovejero-Sánchez, Rogelio González‐Sarmiento, Ana B. Herrero
Neoplasia (2021) Vol. 23, Iss. 5, pp. 515-528
Open Access | Times Cited: 23

Showing 23 citing articles:

Non-apoptotic cell death in ovarian cancer: Treatment, resistance and prognosis
Jinghong Chen, Zhichen Wei, Kaiyu Fu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112929-112929
Open Access | Times Cited: 28
DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
María Ovejero-Sánchez, Rogelio González‐Sarmiento, Ana B. Herrero
Cancers (2023) Vol. 15, Iss. 2, pp. 448-448
Open Access | Times Cited: 15
Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death
Diego Iglesias-Corral, Paula García-Vallés, Nuria Arroyo-Garrapucho, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 19
Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses
Nasreddine El Omari, Saad Bakrim, Asaad Khalid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114886-114886
Open Access | Times Cited: 11
Research for a Common Thread: Insights into the Mechanisms of Six Potential Anticancer Agents
Dóra Varga, Attila Szentirmai, András Szarka
Molecules (2025) Vol. 30, Iss. 5, pp. 1031-1031
Open Access
Clinical Applications of HDAC Inhibitors as Anticancer Agents in Prostate, Breast, Ovarian, and Cervical Cancers
Saad Bakrim, Farah Atifi, Nasreddine El Omari, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines
Mariana Brütt Pacheco, Vânia Camilo, Nair Lopes, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 670-670
Open Access | Times Cited: 23
Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy
Yanqing Liu, Yuqing Meng, Junzhe Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6777-6809
Open Access | Times Cited: 3
Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside
Faqian Bu, Jifa Zhang, Shuai Wen, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1815-1831
Closed Access | Times Cited: 17
Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective
Jiaqi Yao, Chi Ma, Kaixuan Feng, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 11
Curcumin Sensitizes 4T1 Murine Breast Cancer Cells to Cisplatin Through PAR4 Secretion
NORMA CESILIA ARELLANO-RODRÍGUEZ, OSCAR ALBERTO ALVAREZ-QUEZADA, Pablo Zapata Benavides, et al.
In Vivo (2022) Vol. 36, Iss. 6, pp. 2767-2773
Open Access | Times Cited: 8
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer
Ranadip Mandal, Monika Raab, Franz Rödel, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 8
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Fengyi Guo, Hongjing Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Nair Lopes, Sofia Salta, Bianca Troncarelli Flores, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer
Maciej Skrzypczak, Ewa Wolińska, Łukasz Adaszek, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 166-166
Open Access | Times Cited: 1
Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity
María Ovejero-Sánchez, Jorge Rubio-Heras, María del Carmen Vicente de la Peña, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7518-7518
Open Access | Times Cited: 7
Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives
Megha Mehrotra, Pratham Phadte, Priti S. Shenoy, et al.
Advances in experimental medicine and biology (2024), pp. 65-96
Closed Access | Times Cited: 1
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors
Khayal Gasimli, Monika Raab, Ranadip Mandal, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 107-107
Open Access | Times Cited: 2
Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers
Chunxiu Lin, Peng Liu, Chaowen Shi, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 2, pp. 194-214
Closed Access | Times Cited: 3
Knockdown of KDM5B Leads to DNA Damage and Cell Cycle Arrest in Granulosa Cells via MTF1
Yingnan Yang, Yu Cai, Jinjing Guo, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3219-3237
Open Access | Times Cited: 1
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition
Jing‐Ting Chiou, Yuan‐Chin Lee, Long‐Sen Chang
Biochemical Pharmacology (2023) Vol. 218, pp. 115934-115934
Closed Access
Combined targeting autophagy and metabolism for cancer therapy
G. Tripathi, Shambhavi Mishra, Ambarish Priyadarshan, et al.
Elsevier eBooks (2022), pp. 215-238
Closed Access
Page 1

Scroll to top